Alzheimer’s disease research in the future: bibliometric analysis of cholinesterase inhibitors from 1993 to 2012

Huaqi Chen (), Yuehua Wan, Shuian Jiang and Yanxia Cheng
Additional contact information
Huaqi Chen: Taizhou University
Yuehua Wan: Zhejiang University of Technology
Shuian Jiang: Taizhou University
Yanxia Cheng: Zhejiang University of Technology

Scientometrics, 2014, vol. 98, issue 3, No 18, 1865-1877

Abstract: Abstract In this study, the bibliometric study of cholinesterase inhibitors was used to find the trend of Alzheimer’s disease (AD) research and the order of drugs which was most tolerated or more effective in AD treatment. 4,982 articles and reviews from the Science Citation Index Expanded during 1993–2012 were analyzed. The main results were as follows: The publication of cholinesterase inhibitor research increased overall during 1993–2012. Chinese Academy of Science had most publications, University of California, San Diego and Hebrew University of Jerusalem won first place with the highest average citation per paper and the highest h-index respectively. Neurosciences, pharmacology and chemistry were “raising” subject categories in cholinesterase inhibitors research. With the comprehensive analysis of distribution and change of author keywords in two 10-year-time periods, it can be concluded as follows: (i) the order of drugs which was most tolerated or more effective in AD treatment might be donepezil, galantamine, rivastigmine, tacrine, memantine and huperzine A, and memantine attracted increasing interest recently and might be used more frequently now, especially for moderate to severe dementia. (ii) The pathogenesis of oxidative stress hypothesis attracted extensive attention. The interest to β-amyloid cascade hypothesis increased slightly but that of the cholinergic hypothesis decreased during the past decade. (iii) “Oxidative stress”, “β-amyloid”, “neuroprotection”, “memory” and “cognition” are the main orientations in the AD research in the future.

Keywords: Cholinesterase inhibitors; Bibliometrics; SCI; Author keywords analysis; Alzheimer’s disease (search for similar items in EconPapers)
Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://link.springer.com/10.1007/s11192-013-1132-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:scient:v:98:y:2014:i:3:d:10.1007_s11192-013-1132-3

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/11192

DOI: 10.1007/s11192-013-1132-3

Access Statistics for this article

Scientometrics is currently edited by Wolfgang Glänzel

More articles in Scientometrics from Springer, Akadémiai Kiadó
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().